Medicare PBM Restrictions Would Lead To Higher Premiums, CBO Says
Executive Summary
The PBM "transparency" provision in the Senate's Medicare prescription drug bill would lead to higher monthly premiums and higher beneficiary cost-sharing, the Congressional Budget Office said
You may also be interested in...
PBMs Take Aim At Disclosure, Transparency Provisions In House Health Reform Bill
CVS Caremark CEO Tom Ryan predicts during the company's second quarter call that "once CBO scores this, [the transparency provision] will not survive."
PBMs Estimate Costs Of Restrictive Legislation; NCPA Urges “Education”
Legislation requiring PBMs to disclose specific terms of contracts with manufacturers would increase Medicare prescription drug spending by 7%, an analysis commissioned by the Pharmaceutical Care Management Association maintains
PBMs Estimate Costs Of Restrictive Legislation; NCPA Urges “Education”
Legislation requiring PBMs to disclose specific terms of contracts with manufacturers would increase Medicare prescription drug spending by 7%, an analysis commissioned by the Pharmaceutical Care Management Association maintains